Peripheral monocytes derived from patients with cystic fibrosis and healthy donors secrete ngal in response to pseudomonas aeruginosa infection

Journal of Investigative Medicine

Volumn 61, Issue 6, 2013, Pages 1018-1025

  Zughaier, Susu M ^a   Tangpricha, Vin ^a   Leong, Traci ^b   Stecenko, Arlene A ^a   McCarty, Nael A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Biomarker; Cystic fibrosis; Monocyte; NGAL; Pseudomonas aeruginosa

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; CELLULAR IMMUNITY; CELLULAR SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; LUNG INFECTION; MONOCYTE; NEUTROPHIL; NONHUMAN; PERIPHERAL MONOCYTE; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PSEUDOMONAS INFECTION; SEPSIS; BACTERIAL COUNT; BACTERIAL STRAIN; CELL DENSITY; LIVING DONOR; PSEUDOMONAS AERUGINOSA; UPREGULATION;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; COHORT STUDIES; CYSTIC FIBROSIS; FEMALE; HUMANS; LIPOCALINS; MALE; MONOCYTES; PROTO-ONCOGENE PROTEINS; PSEUDOMONAS INFECTIONS; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84888329451     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31829cbd14     Document Type: Article

References (63)

1. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066-1073.
2. McCarty NA. Permeation through the CFTR chloride channel. J Exp Biol. 2000;203:1947-1962.
3. Jordan IK, Kota KC, Cui G, et al. Evolutionary and functional divergence between the cystic fibrosis transmembrane conductance regulator and related ATP-binding cassette transporters. Proc Natl Acad Sci U S A. 2008;105:18865-18870.
4. Sanders DB, Bittner RC, Rosenfeld M, et al. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011;46:393-400.
5. de Boer K, Vandemheen KL, Tullis E, et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011;66:680-685.
6. Schmidt-Ott KM, Mori K, Li JY, et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2007;18:407-413.
7. Kjeldsen L, Johnsen AH, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425-10432.
8. Holmes MA, Paulsene W, Jide X, et al. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure. 2005;13:29-41.
9. Abergel RJ, Clifton MC, Pizarro JC, et al. The siderocalin/enterobactin interaction: a link between mammalian immunity and bacterial iron transport. J Am Chem Soc. 2008;130:11524-11534.
10. Moreau-Marquis S, O'Toole GA, Stanton BA. Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol. 2009;41:305-313.
11. Lamont IL, Konings AF, Reid DW. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Biometals. 2009;22:53-60.
12. Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432:917-921.
13. Chan YR, Liu JS, Pociask DA, et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol. 2009;182:4947-4956.
14. Berger T, Togawa A, Duncan GS, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 2006;103:1834-1839.
15. Draper DW, Bethea HN, He YW. Toll-like receptor 2-dependent and -independent activation of macrophages by group B streptococci. Immunol Lett. 2006;102:202-214.
16. Saiga H, Nishimura J, Kuwata H, et al. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J Immunol. 2008; 181:8521-8527.
17. Abergel RJ, Moore EG, Strong RK, et al. Microbial evasion of the immune system: structural modifications of enterobactin impair siderocalin recognition. J Am Chem Soc. 2006;128:10998-10999.
18. Peek ME, Bhatnagar A, McCarty NA, et al. Pyoverdine, the major siderophore in Pseudomonas aeruginosa, evades NGAL recognition. Interdiscip Perspect Infect Dis. 2012;2012:843509.
19. Tirouvanziam R, Gernez Y, Conrad CK, et al. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci U S A. 2008;105:4335-4339.
20. Yan L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase Yassociated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 2001;276:37258-37265.
21. Ratjen F, Hartog CM, Paul K, et al. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax. 2002;57:930-934.
22. Provatopoulou X, Gounaris A, Kalogera E, et al. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase Yassociated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer. 2009;9:390.
23. Eagan TM, Damas JK, Ueland T, et al. Neutrophil gelatinase Yassociated lipocalin: a biomarker in COPD. Chest. 2010;138:888-895.
24. Haase M, Haase-Fielitz A, Bellomo R, et al. Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease. Curr Opin Hematol. 2010;6:526-532.
25. Smertka M, Chudek J. Using NGAL as an early diagnostic test of acute kidney injury. Ren Fail. 2012;34:130-133.
26. Nymo SH, Ueland T, Askevold ET, et al. The association between neutrophil gelatinase Yassociated lipocalin and clinical outcome in chronic heart failure: results from CORONA. J Intern Med. 2012;271:436-443.
27. Wheeler DS, Devarajan P, Ma Q, et al. Serum neutrophil gelatinase Yassociated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med. 2008;36:1297-1303.
28. Eichler I, Nilsson M, Rath R, et al. Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis. Eur Respir J. 1999;14:1145-1149.
29. Zughaier SM, Zimmer SM, Datta A, et al. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun. 2005;73: 2940-2950.
30. Zughaier SM, Tzeng YL, Zimmer SM, et al. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect Immun. 2004;72:371-380.
31. Bulitta JB, Yang JC, Yohonn L, et al. Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model. Antimicrob Agents Chemother. 2010;54:2051-2062.
32. Soni SS, Cruz D, Bobek I, et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol. 2009;42:141-150.
33. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Kidney Blood Press Res. 2007;30:408-415.
34. Yang J, Mori K, Li JY, et al. Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol. 2003;285:F9-F18.
35. Di A, Brown ME, Deriy LV, et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol. 2006;8:933-944.
36. Del Porto P, Cifani N, Guarnieri S, et al. Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa. PLoS One. 2011;6:e19970.
37. Donnelly LE, Barnes PJ. Defective phagocytosis in airways disease. Chest. 2012;141:1055-1062.
38. Zughaier SM, Ryley HC, Jackson SK. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun. 1999;67:1505-1507.
39. Tan BK, Adya R, Shan X, et al. Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin. Diabetes Care. 2009;32:129-131.
40. Wurfel MM, Park WY, Radella F, et al. Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity. J Immunol. 2005;175:2570-2578.
41. Sveger T, Ohlsson K, Morse H, et al. Plasma neutrophil lipocalin, elastase-alpha1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scand J Clin Lab Invest. 2003;63:89-92.
42. Schmidt-Ott KM, Mori K, Kalandadze A, et al. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens. 2006;15:442-449.
43. Moreton RE, Kennedy CR. C-reactive protein concentrations in cystic fibrosis. Arch Dis Child. 1988;63:958-960.
44. Glass S, Hayward C, Govan JR. Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis. J Pediatr. 1988;113:76-79.
45. Friesen CA, Wiens LA, Burry VF, et al. C-reactive protein in acute pulmonary exacerbations of patients with cystic fibrosis. Pediatr Pulmonol. 1995;20:215-219.
46. Chakraborty S, Kaur S, Guha S, et al. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta. 2012;1826:129-169.
47. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005;115:610-621.
48. Cai L, Rubin J, Han W, et al. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol. 2010;5:2229-2235.
49. Hu L, Hittelman W, Lu T, et al. NGAL decreases E-cadherin Ymediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab Invest. 2009;89: 531-548.
50. Makris K, Rizos D, Kafkas N, et al. Neurophil gelatinase Yassociated lipocalin as a new biomarker in laboratory medicine. Clin Chem Lab Med. 2012;50:1519-1532.
51. Visca P, Imperi F, Lamont IL. Pyoverdine siderophores: from biogenesis to biosignificance. Trends Microbiol. 2007;15:22-30.
52. Rogan MP, Taggart CC, Greene CM, et al. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis. 2004;190:1245-1253.
53. Britigan BE, Hayek MB, Doebbeling BN, et al. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa Yinfected lungs of patients with cystic fibrosis. Infect Immun. 1993;61:5049-5055.
54. Hvidberg V, Jacobsen C, Strong RK, et al. The endocytic receptor megalin binds the iron transporting neutrophil gelatinase Yassociated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005;579:773-777.
55. Bolignano D, Donato V, Lacquaniti A, et al. Neutrophil gelatinase Yassociated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett. 2009;288:10-16.
56. Zografos T, Haliassos A, Korovesis S, et al. Association of neutrophil gelatinase Yassociated lipocalin with the severity of coronary artery disease. Am J Cardiol. 2009;104:917-920.
57. Zhang XF, Zhang Y, Zhang XH, et al. Clinical significance of neutrophil gelatinase Yassociated lipocalin (NGAL) expression in primary rectal cancer. BMC Cancer. 2009;9:134.
58. Yang YH, He XJ, Chen SR, et al. Changes of serum and urine neutrophil gelatinase Yassociated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study. Endocrine. 2009;36:45-51.
59. Woo HJ, Park JC, Bae CH, et al. Up-regulation of neutrophil gelatinase Yassociated lipocalin in cholesteatoma. Acta Otolaryngol. 2009;129:624-629.
60. Bao G, Clifton M, Hoette TM, et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol. 2010;6:602-609.
61. Devireddy LR, Hart DO, Goetz DH, et al. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell. 2010;141:1006-1017.
62. Roudkenar MH, Halabian R, Bahmani P, et al. Neutrophil gelatinase Yassociated lipocalin: a new antioxidant that exerts its cytoprotective effect independent on heme oxygenase-1. Free Radic Res. 2011;45:810-819.
63. Bahmani P, Halabian R, Rouhbakhsh M, et al. Neutrophil gelatinase Yassociated lipocalin induces the expression of heme oxygenase-1 and superoxide dismutase 1, 2. Cell Stress Chaperones. 2010;15:395-403.